IP Library Patent Application 19321894
Patent Application
App. No. 19/321,894

Collagen and Cell Matter Supplement and Method for Administering Same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/321,894
Abstract

The present disclosure is directed to a composition or nutritional supplement containing undenatured Type II collagen in combination with probiotic cell matter and/or a prebiotic. The different dietary or nutraceutical agents are capable of synergistically working together to improve the health and well-being of a human or animal. For instance, the nutritional supplement can be used to treat joint discomfort and pain, improve immune, or otherwise reducing inflammation in human and animal populations both at risk and actively presenting with such ailments.

Claims (18)

1 - 43 . (canceled)

44 . A method of modulating joint health in a mammal comprising:

administering to the mammal a therapeutically effective amount of a nutritional supplement, wherein the nutritional supplement comprises:

a Type II collagen source, wherein the Type II collagen source comprises an undenatured, denatured, or hydrolyzed Type II collagen or bioactive peptide derived from Type II collagen; and

a collagen adjuvant, the collagen adjuvant comprising probiotic cell matter, a prebiotic, or mixtures thereof,

wherein a ratio between the Type II collagen source and the probiotic cell matter, when present, is from 1 mg:3 mg to 1 mg:50 mg, and a ratio between the Type II collagen and the prebiotic, when present, is from 1 mg:1 mg to 1 mg:50,000 mg.

45 . The method of claim 44 , wherein the collagen adjuvant comprises the probiotic cell matter, the probiotic cell matter comprising a probiotic organism, a paraprobiotic, or mixtures thereof.

46 . The method of claim 45 , wherein the probiotic cell matter comprises the probiotic organism, the probiotic organism comprising a bacteria or a eukaryotic organism.

47 . The method of claim 46 , wherein the probiotic organism comprises a strain selected from the Firmicutes , the Gracilicutes , or the Mendocutes , and would include Bacteroidetes, Actinobacteria, Proteobacteria, Lactobacteria , the Bacilli, Verrucomicrobia, Faecalibacteria, Thermophiles , and the Clostridias , or comprises Escherichia coli, Bacteroides fragilis, Bifidobacteria and Lactobacteria, including Lactobacteria casei, Bifidobacterium longum ssp infantis, Lactobacteria johnsonii, Lactobacteria rhamnosus, Lactobacteria reuteri, Lactobacteria acidophilus, Lactobacteria paracasei, Lactobacillus plantarum , and Lactobacillus lundensis, Bacillus coagulans, Bacillus subtilis, Faecalibacteria prausnitzil, Enterococcus faecium, Streptococcus salivarius, Clostridia butyricum, Akkermansia muciniphila , or mixtures thereof.

48 . The method of claim 46 , wherein the probiotic organism comprises an organism from the genus Saccharomycesceae such as Saccharomyces cerevisiae.

49 . The method of claim 45 , wherein the probiotic cell matter comprises a paraprobiotic, wherein in the paraprobiotic comprises lyophilized cells, heat-treated cells, a cell hydrolysate, a cell extract, a cell metabolite, or mixtures thereof.

50 . The method of claim 45 , wherein the probiotic cell matter comprises a paraprobiotic, wherein the paraprobiotic comprises a yeast metabolite or mixture of metabolites optionally combined with a nutrient.

51 . The method of claim 44 , wherein the Type II collagen source and the collagen adjuvant have been blended together or are provided as separate entities.

52 . The method of claim 44 , wherein the nutritional supplement is administered orally.

53 . The method of claim 44 , wherein the collagen adjuvant comprises the prebiotic and wherein the prebiotic comprises arabinogalactans, arabinoxylans, alpha-glucan, beta-glucan, fructo-oligosaccharides, manno-oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides, mammalian milk oligosaccharides, extracellular vesicles, or mixtures thereof.

54 . The method of claim 44 , wherein the nutritional supplement comprises a food product or a beverage.

55 . The method of claim 54 , wherein the nutritional supplement comprises tablets, capsules, gummy chewables, edible films, liquid suspensions, powders, syrups, or lozenges, a yogurt, a fruit juice or other beverage matrix.

56 . The method of claim 44 , wherein the Type II collagen source comprises an undenatured Type II collagen.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LUGO, JIM; SAIYED, ZAINULABEDIN
To: LONZA INC.
Reel/Frame 072187/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LONZA INC
To: LONZA, LLC
Reel/Frame 072187/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LONZA, LLC
To: LONZA AMERICA INC.
Reel/Frame 072187/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LONZA AMERICA INC.
To: LONZA NORTH AMERICA INC.
Reel/Frame 072187/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LONZA NORTH AMERICA INC.
To: INTERHEALTH HOLDINGS II INC.
Reel/Frame 072187/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: INTERHEALTH HOLDINGS II INC.
To: LONZA CONSUMER HEALTH INC.
Reel/Frame 072187/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: LONZA CONSUMER HEALTH INC.
To: CAPSUGEL MANUFACTURING, LLC
Reel/Frame 072187/0896 →
CHANGE OF NAME Recorded Sep 8, 2025
From: CAPSUGEL MANUFACTURING, LLC
To: LONZA GREENWOOD LLC
Reel/Frame 072836/0487 →